Ultrasound Wound Debridement Devices Market Summary
The global ultrasound wound debridement devices market size was estimated at USD 743.49 million in 2024 and is projected to reach USD 1,117.75 million by 2030, growing at a CAGR of 7.05% from 2025 to 2030. The demand for ultrasound devices for wound debridement is rising owing to the increasing burden of chronic wounds and the rising number of surgical cases worldwide.
Key Market Trends & Insights
- The North American ultrasound wound debridement device industry held the largest global revenue share of more than 38.93%, in 2024.
- Over the forecast period, we expect the ultrasound wound debridement devices industry in the U.S. to dominate the North American market.
- By product, the systems segment dominated the market in 2024 and is expected to register the fastest CAGR of 7.80% over the forecast period.
- By end use, the hospital segment held the largest share of 30.38%) in 2024.
- By indication, the acute wounds segment held the largest share in 2024 and is expected to grow at a CAGR during the forecast period.
Market Size & Forecast
- 2024 Market SizeUSD 743.49 Million
- 2030 Projected Market SizeUSD 1,117.75 Million
- CAGR (2025-2030)7.05%
- North AmericaLargest market in 2024
- Asia PacificFastest growing market
According to a study published by the King Abdullah University of Science and Technology, Saudi Arabia, and the Leprosy Control Program, Colombia, in August 2024, chronic wounds affect 40 million individuals worldwide. Over the forecast period, we anticipate that the high burden of chronic wounds will drive the demand for ultrasound wound debridement devices. Ultrasonic wound debridement is an effective and gentle method for cleansing chronic and acute wounds.
This technique allows for the debridement of even hard-to-reach areas without the need for extensive surgery. It is commonly used to treat chronic wounds, such as diabetic foot ulcers, pressure ulcers, and leg ulcers, as well as acute wounds such as burns, postoperative wounds, and trauma-related injuries. As the incidence of these types of wounds continues to rise, the demand for ultrasonic wound debridement devices is expected to grow significantly. According to data published by Aurealis Therapeutics in April 2024, individuals with diabetes face a 19-34% lifetime risk of developing a diabetic foot ulcer (DFU). Globally, the prevalence of DFUs among people with diabetes is estimated at 6.3%. Thus, the increasing prevalence of chronic diseases like diabetes is driving demand for products that aid in treating chronic wounds, such as DFUs and pressure ulcers, boosting the ultrasonic wound debridement devices market.
The graphical representation below demonstrates the growing burden of DFUs in several Asia Pacific countries, such as India, China, Thailand, Australia, and South Korea. The highest burden is anticipated to be in China, which represents potential opportunities for ultrasound wound debridement device industry players to expand their product reach in the Asia Pacific region and capture a significant revenue share.
Several companies, such as Söring GmbH, Mavera Medical, and Esacrom, offer products for treating chronic wounds, including DFUs. Thus, the increasing burden of wounds is anticipated to drive the ultrasound wound debridement devices industry.
"The Söring UAW was able to significantly reduce the bacterial load in the treatment of DFU, not only right after debridement but also during the entire treatment period." Said Mario Gießler, Head of Wound Management, Südharz Clinic Nordhausen, Germany
Moreover, the increasing number of clinical trials and research activities focusing on ultrasound wound debridement devices is anticipated to support the market growth in the coming years.
Market Concentration & Characteristics
The market growth stage is moderate at an accelerating pace. The ultrasound wound debridement devices industry is characterized by moderate growth owing to the rising number of accidental injuries and surgical procedures and the increasing prevalence of chronic wounds.
The companies and researchers are focusing on developing and evaluating devices for ultrasound wound debridement to manage chronic wounds. For instance, in May 2024, the National Library of Medicine published a research study investigating the effect of ultrasound-assisted wound debridement on the healing of DFUs. We anticipate that these studies will spur innovation in the ultrasound wound debridement devices industry.
Regulatory bodies such as Health Canada, the U.S. Food and Drug Administration (FDA), the European Union, and others set quality and safety standards for medical devices, including ultrasound wound debridement devices. These devices are classified into categories, ranging from Class I to Class IV, based on their risk level, with higher-risk categories subject to more stringent regulatory oversight. For example, the FDA classifies ultrasound wound debridement devices as Class II, requiring compliance with applicable voluntary safety standards set by the agency.
Companies are increasingly acquiring development-stage firms to expand their product portfolios and serve a broader patient population. Large corporations often pursue such acquisitions to enhance their market position, diversify their offerings, or gain access to innovative technologies. For instance, in October 2021, Bioventus Inc. acquired Misonix, Inc., a company specializing in minimally invasive therapeutic ultrasonic technologies and regenerative medicine. This acquisition significantly impacted products like the neXus platform, which supports ultrasonic procedures, and SonicOne, a device used for tissue debridement in chronic wounds.
The ultrasound wound debridement devices industry is experiencing regional expansion driven by increasing healthcare investments, rising chronic wound cases, and improved regulatory approvals across North America, Europe, Asia-Pacific, and Latin America.
Product Insights
The systems segment dominated the market in 2024 and is expected to register the fastest CAGR of 7.80% over the forecast period. The demand for ultrasound wound debridement device systems is driven by the growing demand for advanced wound care solutions, the rising prevalence of chronic and surgical wounds, and the need for efficient, non-invasive treatment options. Technological advancements and growing adoption in hospitals and specialty clinics further boost the demand for these systems.
The accessories and consumables segment is expected to experience significant growth during the forecast period. This growth can be attributed to the increasing demand for improved device performance, infection control, and convenience. Consumables play a crucial role in maintaining optimal functionality, hygiene, and portability, which drives the demand for these products in wound care settings. In addition, the rising adoption of advanced ultrasound technology further supports this growth.
Indication Insights
The acute wounds segment held the largest share in 2024 and is expected to grow at a CAGR during the forecast period. This growth is driven by the rising geriatric population and an increasing number of surgical procedures. For example, a study published by the National Library of Medicine in April 2024 found that 1 in 9 individuals in U.S. households reported having at least one surgical procedure in the past year.
The chronic wounds segment is expected to experience moderate growth during the forecast period. This growth is primarily driven by the rising incidence of various chronic wounds, including diabetic foot ulcers (DFUs), pressure ulcers, and leg ulcers. A study published by the MSD Journals in January 2025 reported that over 2.5 million people in the U.S. develop pressure ulcers annually. We expect this significant patient population to further drive the segment's growth.
End Use Insights
The hospital segment held the largest share of 30.38% in 2024. This growth is driven by the rising number of surgical procedures that require ultrasound devices for wound debridement to promote faster healing. Moreover, hospitals are major purchasers of these devices, often securing long-term contracts with suppliers. The segment’s growth during the forecast period is further expected to be driven by the increasing focus on improving patient outcomes and the growing adoption of advanced wound care technologies.
The operating rooms segment is anticipated to grow at the fastest CAGR from 2025 to 2030. This growth is driven by the increasing number of surgeries requiring efficient wound healing, the adoption of advanced ultrasound wound debridement devices, and the rising demand for faster recovery times in surgical settings.
Regional Insights
The North American ultrasound wound debridement device industry held the largest global revenue share of more than 38.93%, in 2024. The key drivers of growth in the region include rising chronic wound cases, an aging population, and increasing adoption of advanced therapies. Favorable reimbursement policies, regulatory support, and strategic acquisitions further boost growth. Moreover, a growing number of research activities and clinical trials are advancing product innovation and effectiveness, enhancing the region’s leadership in wound care technology.
U.S. Ultrasound Wound Debridement Devices Market Trends
The ultrasound wound debridement devices industry in the U.S. is expected to dominate the North American market over the forecast period, driven by the presence of key players like Bioventus, SANUWAVE Health, Inc., and Bioevopeak Co., Ltd., along with a growing emphasis on the development and adoption of ultrasound-based wound care technologies.
Europe Ultrasound Wound Debridement Devices Market Trends
The ultrasound wound debridement devices industry in Europe is expected to experience the fastest growth in the coming years, fueled by an increase in surgical procedures and the presence of key players like Esacrom and Söring GmbH, which provide ultrasound-based solutions for wound management. Furthermore, the rising prevalence of wounds across the region is anticipated to drive market expansion. For instance, data from the Journal of Vascular Societies Great Britain and Ireland projects that by 2025, over 5 million people in the UK will have diabetes, with diabetic foot ulcers (DFUs) affecting 25% of this population.
The UK's ultrasound wound debridement devices industry is projected to experience significant growth in the coming years, driven by an aging population, the rising prevalence of chronic conditions like diabetes, and advancements in ultrasound technology. Increased healthcare investments, government initiatives, and growing awareness of advanced treatment options are also contributing to the rising demand for innovative wound debridement solutions.
France's ultrasound wound debridement devices industry is expected to grow during the forecast period, fueled by the rising prevalence of chronic conditions and substantial healthcare spending. According to data from Urgo Medical, 300,000 patients in France are at risk of developing a pressure ulcer each year.
Asia Pacific Ultrasound Wound Debridement Devices Market Trends
The Asia Pacific ultrasound wound debridement devices industry is expected to register significant growth during the forecast period, driven by the increasing demand for ultrasound wound debridement devices. The growing elderly population, the increasing incidence of chronic diseases like diabetes, and rising healthcare investments drive the regional market. In countries like India and China, the prevalence of ulcers is growing, creating a significant demand for advanced wound care technologies and treatments. Furthermore, the study published by the Frontiers in February 2025 reported the highest number of prevalent cases of decubitus ulcers in South Asia.
China's ultrasound wound debridement device industry is expected to grow throughout the forecast period, driven by the rising demand for solutions to address the increasing incidence of chronic wounds, particularly diabetic foot ulcers (DFUs). A study published by Frontiers in August 2024 found that the incidence of DFUs in China ranges from 17.03% to 42.84%, significantly higher than in other countries. The same study also highlighted a high incidence of amputations among individuals with DFUs in China. This growing prevalence is expected to drive demand for advanced wound management products, including ultrasound devices.
We anticipate growth in India's ultrasound wound debridement devices industry due to rising healthcare needs, technological development, and increasing demand for advanced wound care. For instance, in September 2024, IIT Madras developed a portable ultrasound scanner for sports injury diagnosis, reflecting the country's focus on accessible innovations that can aid wound management.
Latin America Ultrasound Wound Debridement Devices Market Trends
The Latin American ultrasound wound debridement devices industry is driven by a rising burden of chronic wounds, improving healthcare infrastructure, and increasing awareness of advanced treatment options. Government initiatives and expanding access to medical technology further support regional market growth.
Middle East And Africa Ultrasound Wound Debridement Devices Market Trends
The Middle East and Africa ultrasound wound debridement devices industry is driven by rising chronic wound cases, improving healthcare infrastructure, and growing awareness of advanced treatments. For instance, Saudi Arabia’s initiatives, such as Saudi Vision 2030, to enhance healthcare access are fueling demand for innovative wound care solutions, including ultrasound wound debriding devices.
The ultrasound wound debridement devices industry in the UAE is anticipated to grow over the forecast period. The country market is driven by the increasing awareness of advanced wound care solutions, as demonstrated by events like the 14th Abu Dhabi Wound Care Conference (ADWCC) in March 2023. This highlights the country's focus on innovative medical technologies and improving healthcare infrastructure.
Key Ultrasound Wound Debridement Devices Company Insights
Mavera Medical, Esacrom, Bioventus (Misonix Inc.), SANUWAVE Health, Inc., Bioevopeak Co., Ltd., Arobella Medical LLC, Söring GmbH, Alliqua Biomedical, Shenzhen Acare International Industrial Co., Ltd., and GUNZE LIMITED are some of the major players in the ultrasound wound debridement devices industry. These companies are competing through product innovation, strategic partnerships, and expanding their global presence to cater to the increasing demand for ultrasound wound debridement devices.
Key Ultrasound Wound Debridement Device Companies
The following are the leading companies in the ultrasound wound debridement devices market. These companies collectively hold the largest market share and dictate industry trends.
- Mavera Medical
- Esacrom
- Bioventus (Misonix Inc.)
- SANUWAVE Health, Inc
- Bioevopeak Co., Ltd.
- Arobella Medical LLC
- Söring GmbH
- Alliqua Biomedical
- Shenzhen Acare International Industrial Co., Ltd.
- GUNZE LIMITED
Recent Developments
-
In December 2023, a clinical study sponsored by the Mayo Clinic began to explore the use of a high-resolution microvessel ultrasound imaging system to assess scarring, monitor wound healing, and evaluate how treatment impacts the number of tiny vessels and blood circulation around the wound. The study is expected to conclude in December 2025.
-
In March 2024, Tenex Health Inc. completed the clinical study comparing standard of care (SOC) to Tenex MicroTip ultrasound therapy plus SOC in patients with diabetic foot ulcers. The study enrolled approximately 148 participants.
-
In November 2020, Gunze launched its ultrasonic debridement device, marking the debut of the first Japanese product under its subsidiary "Medical U&A."
Ultrasound Wound Debridement Devices Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 795.04 million |
|
Revenue forecast in 2030 |
USD 1,117.75 million |
|
Growth rate |
CAGR of 7.05% from 2025 to 2030 |
|
Base year for estimation |
2024 |
|
Actual data |
2018-2024 |
|
Forecast period |
2025-2030 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2030 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Product, indication, end use, and region |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; and Middle East & Africa (MEA) |
|
Country scope |
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
|
Key companies profiled |
Mavera Medical; Esacrom; Bioventus (Misonix Inc.); SANUWAVE Health, Inc.; Bioevopeak Co., Ltd.; Arobella Medical LLC; Söring GmbH; Alliqua Biomedical; Shenzhen Acare International Industrial Co., Ltd.; GUNZE LIMITED |
|
Customization scope |
We offer free report customization, equivalent to up to 8 analysts' working days, with every purchase. Changes or additions to the scope of the country, region, and segment are possible. |
|
Pricing and purchase options |
Avail yourself of customized purchase options to meet your exact research needs. Explore purchase options |
Global Ultrasound Wound Debridement Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global ultrasound wound debridement devices market report based on product, indication, end use, and region
-
Product Outlook (Revenue, USD Million, 2018-2030)
-
Systems
-
Accessories/Consumables
-
-
Indication Outlook (Revenue, USD Million, 2018-2030)
-
Chronic Wounds
-
Leg Ulcers
-
Diabetic Foot Ulcers (DFU)
-
Pressure Ulcers
-
Other Chronic Wounds
-
-
Acute Wounds
-
Surgical Wounds
-
Plastic and Reconstructive Surgery
-
Neurosurgery
-
Gastrointestinal and Affiliated Organ Surgery
-
Urological Surgery
-
General Surgery
-
Orthopedic Surgery
-
Others
-
-
Split Skin Graft Preparation
-
Burns
-
Trauma Wounds
-
-
-
End Use Outlook (Revenue, USD Million, 2018-2030)
-
Hospitals
-
Operating Rooms
-
Specialty Clinics (Wound care clinics)
-
Home Healthcare
-
Others
-
-
Regional Outlook (Revenue, USD Million, 2018-2030)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
Japan
-
China
-
India
-
South Korea
-
Australia
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy